TIS tissue therapies limited

next agm., page-2

  1. 21 Posts.
    The annual general meeting is scheduled for 28 November 2011. (see Appendix 4E)

    You can email Dr Steven Mercer ([email protected]) for your investor's enquiries and he will reply.

    It is expected that announcements on commercial deal, final EU clinical results and USA device classification would happen at the end of September or early October. Please be patient and hope for the best.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.